Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.

Parmova O, Adamova B

Open source

DOI
10.3389/fneur.2026.1898311
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1898311,
  title = {Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.},
  author = {Parmova O and Adamova B},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1898311},
  url = {https://doi.org/10.3389/fneur.2026.1898311}
}

RIS

TY  - JOUR
TI  - Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.
AU  - Parmova O
AU  - Adamova B
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1898311
UR  - https://doi.org/10.3389/fneur.2026.1898311
ER  - 

APA

O, P., & B, A. (2026). Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1898311

Source records